204 related articles for article (PubMed ID: 1828765)
1. Inhaled procaterol versus salbutamol in bronchial asthma.
Liippo K; Silvasti M; Tukiainen H
Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of procaterol and salbutamol in single inhaled doses].
Crespo Notario JA; Sobradillo Peña V; Garnacho López E; Ansola Zubiaurre PM; Mazo Echániz J
Rev Clin Esp; 1989 Apr; 184(6):297-301. PubMed ID: 2526959
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
Mazza JA; Tashkin DP; Reed CE
Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
[TBL] [Abstract][Full Text] [Related]
4. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
5. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
6. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
[TBL] [Abstract][Full Text] [Related]
7. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L
Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599
[TBL] [Abstract][Full Text] [Related]
8. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
Morin D; Milot J; Turcotte H; Boulet LP
Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
[No Abstract] [Full Text] [Related]
9. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
10. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma.
Sykes AP; Ayres JG
Respir Med; 1990 Mar; 84(2):135-8. PubMed ID: 2371435
[TBL] [Abstract][Full Text] [Related]
11. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371
[TBL] [Abstract][Full Text] [Related]
13. Comparison between oral procaterol and salbutamol in patients with bronchial asthma.
Tukiainen H; Jaakkola J; Torkko M; Terho EO
Curr Med Res Opin; 1988; 11(4):236-41. PubMed ID: 2975204
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilatory effect of inhaled versus oral salbutamol in bronchial asthma.
Louridas G; Kakoura M; Galanis N; Patakas D; Kastritsi K
Respiration; 1983; 44(6):439-43. PubMed ID: 6648053
[TBL] [Abstract][Full Text] [Related]
15. Possible site of bronchodilation due to inhaled procaterol aerosol in asthmatic patients.
Taguchi O; Hida W; Nogami H; Inoue H; Takishima T
Eur J Clin Pharmacol; 1988; 34(5):433-7. PubMed ID: 2974417
[TBL] [Abstract][Full Text] [Related]
16. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
[TBL] [Abstract][Full Text] [Related]
17. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
[TBL] [Abstract][Full Text] [Related]
18. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
19. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
Löfdahl CG; Svedmyr N
Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
